HomeProductsBioactive CompoundsAnti-Infective AgentsHIV ProteaseMericitabine
Chemical structure of CAS 940908-79-2

Mericitabine

In Stock•Starting at $145 for 50 mg•Purity ≥ 97%
CAS No.940908-79-2
MDL No.MFCD22572932
MFC18H26FN3O6
MW399.40
InChI KeyMLESJYFEMSJZLZ-MAAOGQSESA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
50 mg97%$145In Stock
100 mg97%$245In Stock
250 mg97%$463In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.940908-79-2
Product NameMericitabine

Associated Conditions

hepatitis C virus infection·chronic hepatitis C virus infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance.

Antimicrobial agents and chemotherapy • Vol. 58, Issue 6 • 2014
PMID: 24687498PMC: PMC4068438DOI: 10.1128/AAC.00016-14

Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors.

Hepatology (Baltimore, Md.) • Vol. 59, Issue 2 • 2014
PMID: 23913364DOI: 10.1002/hep.26660

Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.

Bioorganic & medicinal chemistry letters • Vol. 23, Issue 16 • 2013
PMID: 23856047DOI: 10.1016/j.bmcl.2013.06.045

Documentation

Similar Products